O'Connell Mj

408 total citations
34 papers, 318 citations indexed

About

O'Connell Mj is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, O'Connell Mj has authored 34 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 10 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in O'Connell Mj's work include Cancer Treatment and Pharmacology (9 papers), Colorectal Cancer Treatments and Studies (5 papers) and Biochemical and Molecular Research (4 papers). O'Connell Mj is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Colorectal Cancer Treatments and Studies (5 papers) and Biochemical and Molecular Research (4 papers). O'Connell Mj collaborates with scholars based in United States. O'Connell Mj's co-authors include Beart Rw, Moertel Cg, Joseph Rubin, Robert G. Hahn, Schutt Aj, Eagan Rt, Edmonson Jh, Stephen Frytak, Joshua T. Rubin and Kvols Lk and has published in prestigious journals such as PubMed.

In The Last Decade

O'Connell Mj

33 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
O'Connell Mj United States	10	195	98	56	56	44	34	318
Comis Rl United States	6	190 1.0×	151 1.5×	33 0.6×	57 1.0×	39 0.9×	11	337
Wittes Re United States	12	215 1.1×	87 0.9×	21 0.4×	112 2.0×	36 0.8×	24	377
N Dobbs United Kingdom	9	213 1.1×	67 0.7×	81 1.4×	71 1.3×	15 0.3×	12	402
G Mathé France	9	170 0.9×	120 1.2×	40 0.7×	37 0.7×	33 0.8×	48	386
Schutt Aj United States	11	227 1.2×	92 0.9×	50 0.9×	135 2.4×	105 2.4×	33	422
F Turpin France	10	247 1.3×	85 0.9×	68 1.2×	18 0.3×	17 0.4×	35	410
E Longeval Belgium	10	294 1.5×	115 1.2×	47 0.8×	112 2.0×	45 1.0×	17	465
Bohumil A. Samal United States	8	196 1.0×	32 0.3×	44 0.8×	27 0.5×	40 0.9×	13	359
Jennifer Flatow United States	7	122 0.6×	150 1.5×	49 0.9×	18 0.3×	20 0.5×	7	356
DavidS. Alberts United States	9	167 0.9×	135 1.4×	67 1.2×	18 0.3×	123 2.8×	9	455

Countries citing papers authored by O'Connell Mj

Since Specialization

Citations

This map shows the geographic impact of O'Connell Mj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O'Connell Mj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O'Connell Mj more than expected).

Fields of papers citing papers by O'Connell Mj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O'Connell Mj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O'Connell Mj. The network helps show where O'Connell Mj may publish in the future.

Co-authorship network of co-authors of O'Connell Mj

This figure shows the co-authorship network connecting the top 25 collaborators of O'Connell Mj. A scholar is included among the top collaborators of O'Connell Mj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O'Connell Mj. O'Connell Mj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mj, O'Connell, et al.. (1987). Clinical studies of biochemical modulation of 5-fluorouracil by leucovorin in patients with advanced colorectal cancer by the North Central Cancer Treatment Group and Mayo Clinic.. PubMed. 185–8. 2 indexed citations

Mj, O'Connell, et al.. (1987). Phase II clinical trial of tricyclic nucleoside phosphate for advanced colorectal cancer.. PubMed. 71(3). 333–4. 8 indexed citations

Jj, Mazza, et al.. (1985). High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase I Pilot Study for the Eastern Cooperative Oncology Group.. PubMed. 12(2 Suppl 3). 117–9. 15 indexed citations

Jh, Edmonson, et al.. (1983). Phase II study of maytansine in advanced sarcomas.. PubMed. 67(4). 401–2. 4 indexed citations

Mj, O'Connell. (1983). Oncologic treatment of pancreatic cancer.. PubMed. 58(1). 47–50. 2 indexed citations

Rw, Beart & O'Connell Mj. (1983). Postoperative follow-up of patients with carcinoma of the colon.. PubMed. 58(6). 361–3. 62 indexed citations

Aj, Schutt, et al.. (1983). Phase II study of ftorafur in previously untreated and treated patients with advanced colorectal cancer.. PubMed. 67(5). 505–6. 3 indexed citations

Aj, Schutt, et al.. (1983). Phase II study of hycanthone in patients with advanced colorectal carcinoma.. PubMed. 67(6). 593–4. 4 indexed citations

Rt, Eagan, et al.. (1981). Early clinical trial of a 1-day intermittent schedule for pentamethylmelamine.. PubMed. 64(8-9). 993–5. 6 indexed citations

10.

Mj, O'Connell, et al.. (1980). Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinoma.. PubMed. 64(2-3). 311–3. 4 indexed citations

11.

OʼFallon, Judith R., O'Connell Mj, Robert G. Hahn, et al.. (1978). Evaluation of a fixed alternating treatment in patients with advanced breast cancer.. PubMed. 1(3). 219–26. 9 indexed citations

12.

Lk, Kvols, et al.. (1978). Phase II study of triazinate and pyrazofurin in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy.. PubMed. 62(5). 837–9. 8 indexed citations

13.

Mj, O'Connell, Adi Shani, Joshua T. Rubin, & Moertel Cg. (1978). Phase II trial of maytansine in patients with advanced colorectal carcinoma.. PubMed. 62(8). 1237–8. 10 indexed citations

14.

Mj, O'Connell, et al.. (1978). Value of preoperative radionuclide bone scan in suspected primary breast carcinoma.. PubMed. 53(4). 221–6. 5 indexed citations

15.

Mj, O'Connell, et al.. (1977). Phase II study of dianhydrogalactitol and ICRF-159 in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy.. PubMed. 61(1). 81–2. 5 indexed citations

16.

Mj, O'Connell, Moertel Cg, Schutt Aj, et al.. (1977). Phase II study of cytosine arabinoside in advanced large bowel cancer.. PubMed. 61(9). 1725–6. 2 indexed citations

17.

Mj, O'Connell, et al.. (1977). Pilot study of two adriamycin-based regimens in patients with advanced malignant lymphomas.. PubMed. 61(1). 65–8. 6 indexed citations

18.

Rt, Eagan, et al.. (1976). Phase II evaluation of VP-16-213 (NSC-141540) and cytembena (NSC-104801) in patients with advanced breast cancer.. PubMed. 60(5). 633–5. 22 indexed citations

19.

Jh, Edmonson, et al.. (1976). Phase II study of VP-16-213 versus dianhydrogalactitol in patients with metastatic malignant melanoma.. PubMed. 60(11). 1681–2. 6 indexed citations

20.

Mj, O'Connell & Wiernik Ph. (1975). Streptozotocin (NSC-85998) in the treatment of lymphoreticular malignancies.. PubMed. 59(2 Pt 1). 443–5.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact